Acta Scientific Pharmaceutical Sciences (ASPS)(ISSN: 2581-5423)

Review Article Volume 5 Issue 7

Nature's Way of Protection: Innate Resistance to Malaria

Ernst Hempelmann*

Center of Cellular and Molecular Biology of Diseases, Instituto de Investigaciones Científicas y Servicios de Alta Tecnología (INDICASAT AIP), City of Knowledge, Republic of Panama

*Corresponding Author: Ernst Hempelmann, Center of Cellular and Molecular Biology of Diseases, Instituto de Investigaciones Científicas y Servicios de Alta Tecnología (INDICASAT AIP), City of Knowledge, Republic of Panama.

Received: May 24, 2021; Published: June 09, 2021

Abstract

The malaria parasite has co-evolved with its human host. This has had a profound effect on the genetic variability in host response to malaria. This review will focus on RBC modifications, such as sickle cell, thalassemia’s, glucose-6-phosphate dehydrogenase deficiency and ovalocytosis frequent in persons living in endemic malaria settings.

Keywords: Malaria; Hemoglobin; Sickle Cell

References

  1. Aidoo M., et al. “Protective effects of the sickle cell gene against malaria morbidity and mortality”. Lancet 9314 (2002): 1311-1312.
  2. Alcaïs A., et al. “Human genetics of infectious diseases: between proof of principle and paradigm”. Journal of Clinical Investigation9 (2009): 2505-2514.
  3. Allison AC. “Notes on sickle-cell polymorphism”. Annals of Human Genetics 19 (1954a): 39-57.
  4. Allison AC. “The distribution of the sickle-cell trait in East Africa and elsewhere, and its apparent relationship to the incidence of subtertian malaria”. Transactions of the Royal Society of Tropical Medicine and Hygiene4 (1954b): 312-318.
  5. Allison AC. “Protection Afforded by Sickle-cell Trait Against Subtertian Malaria Infection”. British Medical Journal4857 (1954c): 290-294.
  6. Allison AC. “Aspects of polymorphism in man”. Cold Spring Harbor Symposia on Quantitative Biology 20 (1955): 239-251.
  7. Allison AC and Clyde DF. “Malaria in African Children with Deficient Erythrocyte Glucose-6-phosphate Dehydrogenase”. British Medical Journal5236 (1961): 1346-1349.
  8. Allison AC. “The discovery of resistance to malaria of sickle-cell heterozygotes”. Biochemistry and Molecular Biology Education 30 (2002): 279-287.
  9. Allison AC. “Genetic control of resistance to human malaria”. Current Opinion in Immunology5 (2009a): 499-505.
  10. Allison AC. “A sickle-cell safari, chapter 8”. in: Sean B Carroll Into the Jungle: Great adventures in the search for evolution, San Francisco, Pearson Benjamin Cummings (2009b): 148-165.
  11. Alving AS., et al. “Enzymatic deficiency in primaquine-sensitive erythrocytes”. Science 3220 (1956): 484-485.
  12. Anstey NM., et al. “Lung Injury in Vivax Malaria: Pathophysiological Evidence for Pulmonary Vascular Sequestration and Posttreatment Alveolar-Capillary Inflammation”. Journal of Infectious Diseases 4 (2007): 589-596.
  13. Barnwell JW., et al. “In vitro evaluation of the role of the Duffy blood group in erythrocyte invasion by Plasmodium vivax”. Journal of Experimental Medicine 5 (1989): 1795-1802.
  14. Beutler E. “Glucose-6-phosphate dehydrogenase deficiency: a historical perspective”. Blood 1 (2008): 16-24.
  15. Brain P. “Sickle-cell Anaemia in Africa”. British Medical Journal 2 (1952): 880.
  16. Canali S. “Researches on thalassemia and malaria in Italy and the origins of the "Haldane hypothesis". Medicina nei Secoli 3 (2008): 827-846.
  17. Cavasini CE., et al. “Duffy the Brazilian Amazon region”. Malaria Journal1 (2007): 167.
  18. Ceppellini R. “Discussion of "Aspects of Polymorphism in Man”. Cold Spring Harbor Symposia on Quantitative Biology 20 (1955): 251-255.
  19. Culleton RL., et al. “Failure to detect Plasmodium vivax in West and Central Africa by PCR species typing”. Malaria Journal1 (2008): 174.
  20. Flatz G. “Hemoglobin E: distribution and population dynamics”. Humangenetik 3 (1967): 189-234.
  21. Flint J., et al. “The population gentics of the haemoglobinopathies”. Balliere’s Clinical Haematology 6 (1993): 215-262.
  22. Guindo A., et al. “X-linked G6PD deficiency protects hemizygous males but not heterozygous females against severe malaria”. PLoS Medicine3 (2007): e66.
  23. Hahn EV and Gillespie EB. "Sickle cell anemia. Report of a case greatly improved by splenectomy. Experimental study of sickle cell formation”. Archives of Internal Medicine 2 (1927): 233-254.
  24. Herrick JB. “Peculiar elongated and sickle-shaped red blood corpuscles in a case of severe anemia”. Archives of Internal Medicine 5 (1910): 517-521. Reprinted in Herrick JB (2001) Peculiar elongated and sickle-shaped red blood corpuscules in a case of severe anemis 1910. Yale J Biol Med 74.3 (1910): 179-184.
  25. Hutagalung R., et al. “Influence of hemoglobin E trait on the severity of Falciparum malaria”. Journal of Infectious Diseases 1 (1999): 283-286.
  26. Ingram VM. “Abnormal human haemoglobins. III. The chemical difference between normal and sickle cell haemoglobins”. Biochimica et Biophysica Acta 2 (1959a): 402-411.
  27. Ingram VM and Stretton AO. “Genetic basis of the thalassaemia diseases”. Nature 4703 (1959b): 1903-1909.
  28. Jarolim P., et al. “Deletion in erythrocyte band 3 gene in malaria-resistant Southeast Asian ovalocytosis”. Proceedings of the National Academy of Sciences of the United States of America 24 (1991): 11022-11026.
  29. Labie D., et al. “Haplotypes in tribal Indians bearing the sickle-gene: evidence for the unicentric origin of the ßS mutation and the unicentric origin of tribal populaton in India”. Human Biology4 (1989): 479-491.
  30. Lapouméroulie C., et al. “A novel sickle cell mutation of yet another origin in Africa: the Cameroon type”. Human Genetics 3 (1992): 333-337.
  31. Lebby R. “Case of absence of the spleen”. Southern Medical Journal 1 (1846): 481-483.
  32. Lehmann H and Raper AB. “Distribution of sickle cell trait in Uganda, and its ethnological significance”. Nature 4168 (1949): 494-495.
  33. Lehmann H and Cutbush M. “Sickle cell trait in southern India”. British Medical Journal 6 (1952): 404-405.
  34. Liu SC., et al. “Molecular defect of the band 3 protein in southeast Asian ovalocytosis”. The New England Journal of Medicine 22 (1990): 1530-1538.
  35. López C., et al. “Mechanisms of genetically-based resistance to malaria”. Gene 1-2 (2010): 1-12.
  36. Luzzatto L., et al. “Glucose-6-phosphate dehydrogenase deficient red cells: Resistance of infection by malaria parasites”. Science 164 (1969): 839-841.
  37. Mason VR. “Sickle cell anemia”. JAMA 79 (1922): 1318-1320.
  38. May J., et al. “Hemoglobin variants and disease manifestations in severe falciparum malaria”. JAMA 20 (2007): 2220-2226.
  39. Ménard D., et al. “Plasmodium vivax clinical malaria is commonly observed in Duffy-negative Malagasy people”. Proceedings of the National Academy of Sciences of the United States of America13 (2010): 5967-5971.
  40. Mendes C., et al. “Duffy negative antigen is no longer a barrier to Plasmodium vivax - molecular evidences from the African West Coast (Angola and Equatorial Guinea)”. PLOS Neglected Tropical Diseases 6 (2011): e1192.
  41. Miller LH., et al. “The resistance factor to Plasmodium vivax in blacks. The Duffy-blood-group genotype, FyFy”. The New England Journal of Medicine6 (1976): 302-304.
  42. Modiano G., et al. “Protection against malaria morbidity: near-fixation of alpha-thalassemia gene in a Nepalese population”. American Journal of Human Genetics 48 (1991): 390-397.
  43. Modiano D., et al. “Haemoglobin C protects against clinical Plasmodium faciparum malaria”. Nature 6861 (2001): 305-308.
  44. Montalenti G. “Comment on Haldane, JBS. Disease and evolution”. Rice Science 19 (1949): 333-334.
  45. Pauling L., et al. “Sickle cell anemia, a molecular disease”. Science2865 (1949): 543-548.
  46. Piel FB., et al. “Global distribution of the sickle gene and geographical confirmation of the malaria hypothesis”. Nature Communication8 (2010): 1-7.
  47. Ryan JR., et al. “Evidence for transmission of Plasmodium vivax among a duffy antigen negative population in Western Kenia”. American Society of Tropical Medicine and Hygiene 4 (2006): 575-581.
  48. Santos-Ciminera PD., et al. “Malaria Diagnosis and Hospitalization Trends, Brazil”. Emerging Infectious Diseases 10 (2007): 1597-1600.
  49. Stamatoyannopoulos G and Fessas P. “Thalassemia, glucose-6-phosphate dehydrogenase deficiency, sickling and malarial endemicity in Greece. A study of five areas”. British Medical Journal5387 (1964): 875-879.
  50. Terrenato L., et al. “Decreased malaria morbidity in the Tharu people compared to sympatric populations in Nepal”. Annals of Tropical Medicine and Parasitology 1 (1988): 1-11.
  51. Tournamille C., et al. “Disruption of a GATA motif in the Duffy gene promotor abolishes erythroid gene expression in Duffy-negative individuals”. Nature Genetics2 (1995) 224-228.
  52. Wertheimer SP and Barnwell JW. “Plasmodium vivax interaction with the human Duffy blood group glycoprotein: identification of a parasite receptor-like protein”. Experimental Parasitology 4 (1989): 340-350.
  53. World Malaria Report 2014, World Health Organization, 20 Avenue Appia, CH-1211 Geneva 27, Switzerland (2014).
  54. Williams TN., et al. “Negative epistasis between the malaria-protective effects of alpha+-thalassemia and the sickle cell trait”. Nature Genetics 37 (2005): 1253-1257.

Citation

Citation: Ernst Hempelmann. “Nature's Way of Protection: Innate Resistance to Malaria". Acta Scientific Pharmaceutical Sciences 5.7 (2020): 73-81.

Copyright

Copyright: © 2020 Ernst Hempelmann. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.




Metrics

Acceptance rate32%
Acceptance to publication20-30 days

Indexed In




News and Events


  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is July 15, 2022.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of “Best Article of the Issue”.
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.
  • Contact US